The use of herbs against neglected diseases: Evaluation of leishmanicidal and trypanocidal activity of Mart.

Journal: Saudi journal of biological sciences
Published Date:

Abstract

The evaluation of the leishmanicidal and trypanocidal activity of the hydroalcoholic extract of the bark of Mart. (EHCSR) was carried out to find an alternative treatment for parasitic diseases. EHCSR was prepared and used at four different concentrations (1000, 500, 250, 125 μg/mL) in assays for activity against Leishmania promastigotes using the species and and for trypanocidal activity using the epimastigotes of . We also tested EHCSR for cytotoxicity against adhered cultured Murine J774 fibroblasts. The tests were performed in triplicate, and the percent mortality of parasites, IC and percent toxicity were determined. With regard to anti-leishmania activity against , there was a mean mortality of 45% at all concentrations, and against , a substantial effect was seen at 1000 μg/mL with 56.38% mortality, where the IC values were 1338.76 and 987.35 μg/mL, respectively. Trypanocidal activity was notably high at 1000 μg/mL extract with 82.31% mortality of epimastigotes. Cytotoxicity at the highest extract concentrations of 500 and 1000 μg/mL was respectively 75.12% and 94.14%, with IC = 190.24 μg/mL. Despite that the extract has anti-parasitic activity, its substantial cytotoxicity against fibroblasts cells makes its systemic use nonviable as a therapeutic alternative.

Authors

  • Vivianne C S Vandesmet
    Faculdade Leão Sampaio, Juazeiro do Norte (CE), Brazil.
  • Cicero F B Felipe
    Laboratory of Pharmacology and Molecular Chemistry and Laboratory of Pharmacology of Natural Products, Center of Biological Sciences and Health, Regional University of Cariri, Crato, CE, Brazil.
  • Marta R Kerntopf
    Pharmacology of Natural Products Laboratory, Regional University of Cariri-Campus of Pimenta, 63105-010, Crato, CE, Brazil.
  • Miriam Rolón
    Centre for the Development of Scientific la Investigación (CEDIC), Fundación Moisés Bertoni/Laboratorios Diaz Gill, Asuncion, Paraguay.
  • Celeste Vega
    Centre for the Development of Scientific la Investigación (CEDIC), Fundación Moisés Bertoni/Laboratorios Diaz Gill, Asuncion, Paraguay.
  • Cathia Coronel
    Centre for the Development of Scientific la Investigación (CEDIC), Fundación Moisés Bertoni/Laboratorios Diaz Gill, Asuncion, Paraguay.
  • Andreza G R Barbosa
    Laboratório de Farmacologia e Quimica Molecular, Universidade Regional do Cariri, Crato (CE), Brazil.
  • Henrique D M Coutinho
    1 Universidade Regional do Cariri, Crato, Brasil.
  • Irwin R A Menezes
    1 Universidade Regional do Cariri, Crato, Brasil.

Keywords

No keywords available for this article.